Sentence examples for improve joint damage from inspiring English sources

11, 12 Furthermore, topical treatments and phototherapy do not improve joint damage that is ongoing in psoriatic arthritis, and traditional systemic agents can cause long-term organ damage, such as pulmonary fibrosis and cirrhosis in patients on methotrexate.

Knee and hip arthroplasties are designed to replace biological materials that have been damaged, to relieve pain and improve joint function and quality of life.

First, they were asked to rate on a 5-point scale the importance of: 1) improving joint pain; 2) preventing joint damage; 3) improving physical function; 4) avoiding side effects; 5) becoming pregnant /starting a family; 6) drinking alcohol.

Further research is required to determine the potential of targeting MGCs to improve pain and joint damage both in OA and in RA.

TBAs reduce joint inflammation, slow down joint damage and improve physical function [ 4, 5].

These different mechanisms of action provide a rationale for combining these two commonly used drugs to improve the prevention of structural joint damage in RA.

40 The development of additional therapeutic strategies is necessary to prevent joint damage and improve quality of life in refractory patients or subjects who experience adverse effects.

These two different mechanisms of action provide support for the use of a combination of these two drugs to improve the prevention of structural joint damage in RA.

As functional outcomes are associated with structural damage in progressive RA, 30– 32 treatments that can both improve physical function and inhibit joint damage may help prevent long-term disability.

Agents that block TNF, have been shown to significantly reduce joint inflammation, slow radiographic progression of joint damage, and improve physical function in clinical studies of both advanced and early RA [ 13, 18, 72, 73] and this may have had some influence on the rate of the radiographic progression in this study.

Therapies in rheumatoid arthritis (RA) have evolved from symptomatic treatments to non-biological disease modifying antirheumatic drugs (DMARDs) such as methotrexate (MTX). 1 2 Over the past 15 years, biological immunomodulating therapies have been shown to slow the progression of joint damage and improve the clinical manifestations of RA superior to DMARDs.